The importance of the one-carbon metabolites, choline and homocysteine, to brain function is well known. However, the associations between the one-carbon metabolites choline, betaine, methionine and dimethylglycine with cognition in elderly are unclear. We therefore examined the associations of these metabolites with cognition in a double-blind, placebo-controlled trial. Individuals (n 195) were randomized to receive daily oral capsules with either 1000 mg cobalamin (vitamin B 12 ), or 1000 mg cobalamin plus 400 mg folic acid, or placebo for 24 weeks. Concentrations of homocysteine, methionine, choline, betaine and dimethylglycine were assessed before and after 12 and 24 weeks of treatment. Cognitive function, including domains of attention, construction, sensomotor speed, memory and executive function, was assessed before and after 24 weeks of treatment. At baseline, elevated plasma homocysteine was associated with lower performance of attention, construction, sensomotor speed and executive function. In addition, betaine was positively associated with better performance of construction, sensomotor speed and executive function, whereas elevated concentrations of methionine were positively associated with sensomotor speed. Daily combined supplementation with cobalamin plus folic acid decreased total homocysteine concentrations by 36 %, and increased betaine concentrations by 38 %. Participants with the largest increases in betaine concentrations showed a borderline significant (P¼0·07) higher memory performance compared to those without it. Although this trial observed associations of homocysteine and betaine with cognitive domains prior to supplementation, decreased concentrations of homocysteine were not related to improved cognitive performance. There was a tendency of participants with the largest increases in betaine concentrations to show the greatest improvement in memory function.
Elucidation of the risk factors for cognitive decline is required to prevent and possibly reverse age-related cognitive impairment in elderly people. In this respect, the one-carbon metabolism is of interest because plasma concentrations of homocysteine and related B-vitamins have been associated with cognitive impairment 1 -6 . Moreover, choline plays an important role in normal brain development, in particular for memory and learning 7 .
The metabolites of the one-carbon metabolism are closely interrelated 8,9 . Homocysteine is located at a critical metabolic branch point with ramification to methyl-and sulphur group metabolism ( Fig. 1) . Homocysteine is formed from the essential amino acid methionine. Methionine is activated by its conversion to S-adenosylmethionine, and S-adenosylmethionine is required for methylation of many acceptor substrates, such as DNA, RNA, lipids, proteins, phosphatidylethanolamine, creatine, myelin basic protein and neurotransmitters 10 . Methylation of, for example, phosphatidylethanolamine to form phosphatidylcholine, is important to maintain myelin sheaths of nerve tissue and thereby for central nervous system structure and function 7 . Homocysteine is remethylated to methionine by the cobalamin (vitamin B 12 )-dependent enzyme, methionine synthase, which uses 5-methyltetrahydrofolate as a methyl donor. Deficiencies of folate and cobalamin impair this conversion and result in increased homocysteine concentrations 11 . In a few tissues, predominantly the liver and kidneys, homocysteine remethylation is also catalysed by the enzyme betaine-homocysteine methyltransferase. Methionine and dimethylglycine (DMG) are the products of this reaction. The methyl donor, betaine, is formed from choline, which also is a precursor for the neurotransmitter acetylcholine 12 . Conceivably, impaired one-carbon metabolism may be associated with cognitive impairment by affecting neurotransmitter metabolism and central nervous system function.
Following the epidemiological associations found between homocysteine, cobalamin and folate with cognitive performance 1 -6 , recent intervention trials investigated the efficacy of homocysteine lowering with B-vitamin supplementation on cognitive function in elderly people 13 -15 . However, the associations of plasma concentrations of choline, betaine, DMG and methionine with cognitive performance have not been explored yet. A recently conducted efficacy trial, investigating the efficacy of oral cobalamin with or without folic acid supplementation on cognitive function 14 , provided such an opportunity. In addition, we assessed whether supplementation with cobalamin and folic acid altered plasma concentrations of choline, betaine and DMG, and consequently, whether alterations in these metabolites were associated with improvements in cognitive function.
Subjects and methods

Participants
Elderly men and women aged 70 years or older were screened for participation in a randomized double-blind placebo-controlled trial that studied the efficacy of oral cobalamin supplementation on cognitive performance 14 . Individuals were included when they had mild cobalamin deficiency, defined as serum cobalamin concentrations between 100 and 300 pmol/l in combination with plasma methylmalonic acid concentrations $0·32 mmol/l and serum creatinine concentration # 120 mmol/l to exclude severe impairment of renal function 16 . Other exclusion criteria were history of cobalamin deficiency, use of cobalamin (.50 mg/d) or folic acid (. 200 mg/d) supplementation or injections, surgery or diseases of the stomach or small intestine, anaemia, life-threatening diseases, severe hearing or visual problems, and severe cognitive impairment, which was defined by a score ,19 points on the Mini-Mental State Examination (MMSE). An additional sample of individuals with adequate cobalamin status and no severe cognitive impairment (n 40) was enrolled for cross-sectional data analysis. Figure 2 presents the recruitment procedure, study design and flow of participants. The Medical Ethical Committee of Wageningen University approved the study protocol. Daily boards and client councils gave their consent for those individuals living in an institution, and written informed consent from all participants was obtained before the start of the study.
Study design of the intervention trial
Individuals who were included in the intervention trial started with a 2-week placebo run-in period prior to randomization. Within this period, individuals were excluded from further participation if compliance (intake of capsules) was , 90 %, or if they scored , 19 points on the MMSE. Eligible participants were randomized to receive 24 weeks of treatment in a parallel group design with daily oral doses of 1000 mg cobalamin, a combination of 1000 mg cobalamin and 400 mg folic acid, or a placebo capsule. Randomization was stratified according to methylmalonic acid concentration at the screening visit (below and above 0·45 mmol/l), age (below and above 80 years), sex and MMSE (below and above 24 points).
Blood collection and biochemical analyses
A blood sample was collected at the screening and baseline visit and after 12 and 24 weeks of supplementation. A blood , homocysteine (Hcy), choline, betaine and the one-carbon metabolism. The conversion from Hcy to methionine (Met) can be catalysed by methionine synthase (MS) and betaine-homocysteine methyltransferase (BHMT). The conversion via MS requires cobalamin and 5-methyltetrahydrofolate (THF) as a methyl donor and couples folate metabolism to the choline-betaine pathway. Choline is provided by food or can be formed de novo via sequential S-adenosylmethionine (SAM)-dependent methylation of phosphatidylethanolamine (PE) to form phosphatidylcholine (PC) by phosphatidylethanolamine N-methyltransferase (PEMT). Choline is a precursor for the neurotransmitter acetylcholine or it is oxidized to betaine. Betaine donates its methyl group directly to homocysteine for the conversion into methionine, and results in dimethylglycine (DMG) in the BHMT reaction. CBS, cystathionine-b-synthase; CH 3 THF, methyltetrahydrofolate; cysta, cystathionine; MTR, methionine synthase; SAH, S-adenosylhomocysteine. sample for measurement of methionine, total homocysteine (tHcy), choline, betaine and DMG was collected into a 10 ml Vacutainer w tube containing EDTA. This blood sample was placed in ice-water and centrifuged at 2600 rpm for 10 min at a temperature of 48C within 30 min of collection. All plasma samples were stored at 2 808C prior to laboratory analyses. Plasma concentrations were determined by a method based on methylchloroformate derivatization and GC -MS (methionine and tHcy) 17 and a modification of a method based on liquid chromatography tandem MS (choline, betaine and DMG) 18 . Analytical CV of the assays for methionine, tHcy, choline, betaine and DMG were , 3·4, , 2·2, ,10, , 10 and , 10 %, respectively 17, 18 .
Assessment of cognitive function
Six trained and registered neuropsychologists performed cognitive testing of the participants during a 1·5 -2 h session during the run-in period and at week 24 of intervention. The cognitive test battery consisted of tests that have been shown sensitive to the effects of B-vitamin treatment and ageing in previous studies 2, 19 . Individuals were screened by the MMSE, and those with an MMSE score , 19 points (maximum 30 points) were excluded because of severe cognitive impairment 20 . Table 1 lists the order of assessment and description of the tests, including its corresponding cognitive domain and neuropsychological focus. All these single tests were clustered into domains of attention, construction, sensomotor speed, memory and executive function, as indicated in the statistical methods. Three out of five domains were assessed by at least two tests that measured different aspects and/or degrees of complexities, which has been proposed as the preferred method for cognitive testing 21 . The advantages of clustered scores are (1) the reduction of measurement errors by possible floor and ceiling effects from difficult and easy tests, respectively; (2) to be able to account for missing data; (3) data reduction and thereby reducing chance findings; and finally (4) a better sensitivity to measure cognitive changes 21, 22 .
Statistical methods
The average concentrations of the biochemical parameters at the screening and randomization visits were calculated for each individual, and defined as 'baseline' concentrations. Differences in concentrations of blood parameters at baseline and follow-up were assessed with a two-factor repeated measures ANOVA (two measurements £ three treatment groups) that included the time £ treatment interaction. Tukey post hoc tests were used to assess differences between the intervention groups.
Data on cognitive function were presented as the neuropsychological domains of attention, construction, sensomotor speed, memory and executive function. The domains of attention and construction were assessed by a single cognitive test, while the other domains were assessed by multiple tests. All crude test scores were transformed to z-scores by: zscore ¼ ((individual result -mean result of study population at baseline)/standard deviation of study population at baseline). The multiple tests for the domains of sensomotor speed, memory and executive function were clustered to provide compound z-scores to reduce the effects of chance findings and to simplify interpretation of the cognitive data:
Tests that were clustered for each cognitive domain were highly correlated (P values ranged from , 0·0001 to 0·04 for all tests). Some participants were unable to complete all tests because of performance difficulties, e.g. tiredness. Compound z-scores were calculated when data for at least two, four and five tests for the domains of sensomotor speed, memory and executive function, respectively, were available. The compound z-scores served as 'internal' z-scores from 896 
Cross-sectional associations
Effects of intervention on one-carbon metabolites, and effect of metabolites on cognitive performance Similarities (WAIS) 43 Executive function Verbal reasoning Mention similarities between five pairs of nouns 4·9^2·9 (max. 12) Verbal Fluency, letter 44 Executive function Word generation List as many nouns beginning with letter P (0 weeks) or G (24 weeks) as possible in 2 min
15·4^6·9 nouns listed
Verbal Fluency, animal 44 Executive function Word generation List as many animals as possible in 1 min 17·5^5·7 animals listed GDS 45 Emotional which z-scores at baseline and 24 weeks by study treatment were derived. Baseline information of the present study population with mild cobalamin deficiency combined with an additional group of elderly with adequate cobalamin status enabled us to explore associations between the one-carbon metabolites and cognitive performance by means of partial correlation coefficients which were corrected for age and education.
Per protocol analyses were performed, including only the 162 participants (84 %) who completed the trial. Changes in cognitive performance associated with alterations of metabolite concentration were calculated by subtracting z-scores at the end of the intervention study by the z-scores at baseline. The potential effects of changes in metabolites on cognitive function within each domain within and across tertile categories in biochemical changes were studied by a two-factor repeated measures analyses (two measurements £ three tertile categories) for each cognitive domain that included the time £ tertile category interaction term. These analyses were performed with mixed models (SAS PROC MIXED procedure 23 ), an extension from the linear regression model that includes random effects. Possible inter-investigator bias of the six neuropsychologists was entered as random effects. Statistical analyses were conducted using SAS statistical software version 9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Characteristics of participants
Cross-sectional analyses have been performed for 202 elderly with mild cobalamin deficiency and forty elderly with adequate cobalamin status. The mean age of these participants was 81 (SD 6) years, 74 % of the participants were females, and 40 % of the participants lived in a care facility home. The mean score on the MMSE was 27 (SD 3) points which indicates that most of the population had intact cognitive function or only mild impairment.
The demographic, lifestyle and co-morbidity characteristics of participants are presented in Table 2 . Although there were some differences with respect to lifestyle, medical history and mental status between those with mild cobalamin deficiency and those with adequate cobalamin status, there were no differences between those with mild cobalamin deficiency and the total population used for cross-sectional analyses ( Table 2 ). Of the individuals with mild cobalamin deficiency who started with the run-in period (n 202), seven showed second thoughts, resulting in 195 participants who underwent random assignment. Two of these 195 participants dropped out during the run-in period, which left data for 193 participants who started supplementation (Fig. 2) . 
Blood indices and cognitive function before supplementation
Mean concentrations for methionine (25·1 mmol/l), choline (8·0 mmol/l), betaine (32·2 mmol/l) and DMG (3·7 mmol/l) in the total screened population (n 896) did not differ from those concentrations observed in the segment of participants involved in the intervention trial (n 193; P. 0·05 for all indices (unpaired t-test)). Partial correlation coefficients between the blood indices of the total screened population (n 896), which were corrected for age and sex, are presented in Table 3 . Consistent with the inclusion criteria of mild cobalamin deficiency, participants of the intervention trial had lower cobalamin concentrations and higher tHcy concentrations compared to the total screened population (both P,0·0001). Partial correlation coefficients, which were corrected for age and education, revealed inverse associations of tHcy concentrations with compound scores for the domains of attention, construction, sensomotor speed and executive function. Methionine concentrations were positively associated with the domain of sensomotor speed, whereas betaine concentrations were positively associated with the domains of construction, sensomotor speed and executive function ( Table 3 ). Further adjustment of our analysis for emotional status and other co-morbidity factors did not affect these associations (data not shown). Moreover, the observed associations did not essentially differ between mildly cobalamindeficient participants and those cobalamin-replete subjects (data not shown). Table 4 presents the concentrations of vitamins and the onecarbon metabolites at baseline and at 24 weeks of supplementation. Concentrations of all metabolites in the placebo group remained stable throughout the study period. The time £ treatment interaction term was significant for cobalamin, tHcy, erythrocyte folate (P, 0·0001 for these indices) and betaine (P¼0·030), which indicates differences in effects between the intervention groups. The effects of treatment did not differ between the intervention groups (no significant interaction terms) for methionine, choline and DMG. Nevertheless, concentrations of methionine and choline increased significantly by 11 and 23 %, respectively, after combined supplementation.
Changes in blood indices during intervention
Cognitive performance and changes in blood indices
No differences in cognitive performance between intervention groups were observed at baseline. Since some participants were unable to complete all tests, data of 141, 158 and 151 participants were included for analyses on the domains of sensomotor speed, memory and executive function, respectively. There were no significant effects of increases in erythrocyte folate and cobalamin concentrations on cognitive performance, and this had been described elsewhere 14 . Table 5 presents mean changes in cognitive scores according to changes in tHcy, methionine, choline, betaine and DMG, which are categorized into tertiles. In the domain of memory, the time £ tertile category interaction term was only significant for DMG (P¼0·04), and borderline significant for betaine (P¼0·07), which indicates differences in memory improvement between the tertiles. Participants with the largest increases in betaine concentrations (third tertile category; change in betaine concentrations . 6·88 mmol/l) showed the highest increase in memory performance compared to those in the first and second tertiles. For DMG, participants in the second and third tertiles had a better memory performance compared to those in the first tertile. With respect to the other cognitive domains, no effects within and between tertiles were observed. Further adjustment of our analysis for emotional status and other co-morbidity factors did not affect these associations (data not shown). With respect to emotional status, there were no significant changes in Geriatric Depression Scores between the intervention groups after 24 weeks of supplementation (P¼0·32). Table 3 . Partial Spearman rank correlation coefficients between one-carbon metabolites and vitamins with one-carbon metabolites, and between one-carbon metabolites with compound cognitive domains in a Dutch elderly population (n 242) prior to supplementation Mean changes in z-scores with unlike superscript letters were significantly different (P,0·05). * At baseline, mean compound z-scores were essentially 0 (SD 1), as a result of standardizing and combining crude cognitive scores into standardized compound z-scores. Analyses are adjusted for age, education and neuropsychologists. The cut-off points for tertile categories in changes of tHcy were 23·95 and 20·7 mmol/l; for methionine they were 21·32 and 2·88 mmol/l; for choline they were 2 0·17 and 1·48 mmol/l; for betaine they were 2 1·43 and 6·88 mmol/l; and for DMG they were 20·33 and 0·41 mmol/l. P values indicate tests for trend across median changes in concentrations for each tertile. Analyses are corrected for age, education and neuropsychologist.
Discussion
The present study showed that elevated plasma tHcy was associated with lower performance of attention, construction, sensomotor speed and executive function. In addition, betaine was positively associated with better performance of construction, sensomotor speed and executive function, whereas elevated concentrations of methionine were positively associated with sensomotor speed prior to supplementation. Daily oral supplementation of 1000 mg cobalamin with 400 mg folic acid for a period of 24 weeks decreased tHcy concentrations and increased betaine concentrations. There was a tendency for participants with the largest increases in betaine concentrations to show the greatest improvement in memory function. To our knowledge, the current study is the first one that explores associations of cognitive function with choline, betaine and DMG in an elderly population. Previous animal 24, 25 and human 8, 9, 26 studies indicate a strong interrelationship between the betaine-homocysteine methyltransferase and methionine synthase pathways. This is reflected in lower hepatic choline concentrations during folate deficiency 25, 26 and vice versa 24 , inverse relations between betaine and homocysteine during folate deficiency 8 , and increased betaine concentrations after folic acid supplementation 9 . The latter findings 9 are in line with results of the present trial.
Conceivably, diseases associated with high plasma tHcy concentrations may not only be linked to low concentrations of cobalamin and folate, but also with low concentrations of betaine and choline. So far, only one non-placebo-controlled pilot study in eight patients with Alzheimer's disease 27 have investigated the effect of oral betaine supplementation, and their results were negative. In contrast, the present trial showed that participants with the largest increases in betaine concentrations (third tertile category; change in betaine concentrations .6·88 mmol/l) showed the highest increase in memory performance compared to those in the first and second tertile categories. Given the fact that the changes in betaine and homocysteine concentrations were most pronounced in the group supplemented with cobalamin plus folate, and were related to the increase in erythrocyte folate concentrations (Table 3) , it is possible that folate supplementation accounted for the observed cognitive changes. However, of the recently reported trials 13 -15 , only the FACIT trial has observed a beneficial effect of folate supplementation on memory function 15 . The inconclusive results among the reported trials could possibly be explained by variations in study durations, sample sizes, characteristics of study population and assessment of cognitive function.
The apparent effect of the increase in betaine concentrations on improved memory function may also reflect greater availability of choline metabolites for synthesis of the neurotransmitter acetylcholine and several phospholipids, such as phosphatidylcholine and sphingomyelin 28 . Choline metabolism is closely related to several aspects of the central nervous system function and structure. An adequate supply of choline appears to be essential for fetal cholinergic neuronal development, in particular for brain regions involved in learning and memory processes 28 . Choline is a precursor of brain sphingomyelin, which is a component of white matter myelin 7 . It has been proposed that changes in white matter sphingomyelin or phospholipid content precede clinical deterioration in demyelinating diseases such as multiple sclerosis 29 . There is some evidence that supplementation with cytidinediphospho-choline could protect against and prevent memory impairment in ageing rats 30, 31 , and has beneficial effects on memory and behaviour in elderly people with cognitive problems 32 . The present study describes the association of plasma choline with cognitive status, and the absence of associations prior to supplementation is inconsistent with the hypothesis that choline status is related to cognitive impairment. The lack of associations between plasma choline and cognitive function in the present study may reflect the possibility that plasma free choline represents only a minor fraction of the total choline pool 7 , and may be a poor marker of choline status and metabolism in the brain, which has also been previously suggested 33 .
For DMG, participants in the second and third tertile had a better memory performance compared to those in the first tertile. This observation may reflect changes in cognition during altered betaine metabolism because there is a positive relation between the two metabolites at low but not high DMG concentrations 8 . However, the DMG -memory association could be a chance finding. This possibility is strengthened by the observation that DMG did not change during the intervention.
In summary, the present trial is the first to explore associations of cognitive function with choline, betaine and DMG. We observed associations of homocysteine and betaine with cognitive domains prior to B-vitamin supplementation. Furthermore, there was a tendency that participants with the largest increases in betaine concentrations due to combined supplementation with cobalamin plus folic acid showed the greatest improvement in memory performance.
